by Anthony Pedicelli | May 16, 2022 | Uncategorized
With this approval, Benuvia has begun focusing on four primary psychedelic ingredients: Psilocybin, N,N-Dimethyl-5-Methoxy-Tryptamine (5-MeO DMT), Dimethyltryptamine (DMT), and 3,4-Methylenedioxymethamphetamine, or MDMA Benuvia will manufacture psychedelic APIs in its...
by Molly Stone | Jan 18, 2021 | Uncategorized
Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) announced on January 6, 2021 a definitive agreement to acquire the global development and commercialization rights to Benuvia Therapeutics Inc.’s (“Benuvia”) synthetic cannabidiol oral solution (“RAD011”)....
by Molly Stone | Jan 14, 2021 | Uncategorized
Valeria Coscia, Ph.D. , Bill DuBay, Ph.D., Paul Evans, and Mike Wittmann, Ph.D. will strategically advise Benuvia Manufacturing, a growing, privately held company. ROUND ROCK, TEXAS. January 14, 2021 – Benuvia Manufacturing, Inc, a leading CDMO providing small...
by Molly Stone | Jan 5, 2021 | Uncategorized
Do you have pharmaceutical and CDMO experience? Do you want to be a part of a growing company? Benuvia Manufacturing is the place for you! We are seeking a variety of positions. Please click each link to be taken to the job listing and job application instructions:...
by Molly Stone | Jan 4, 2021 | Uncategorized
Having all capabilities housed under one roof in our Round Rock facility provides a multitude of benefits for our clients. Clients receive quick response, immediate action and a team approach to product development. Jim Mitchell, Senior Director for API Research &...
by Molly Stone | Nov 6, 2020 | Uncategorized
Benuvia Manufacturing is growing! Seeking a dynamic individual with leadership and motivation skills with an extensive knowledge of Pharma CDMO operations and cGMP. The Plant Manager is a strategic partner within the facility who coordinates production activities with...
